Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · NEOGEN

NEOGEN

CommoditiesChemicals & Petrochemicals₹8402 cr market cap
₹2888.50 ▲ +3.9% today As of 19 Nov 2026
52-week low ₹979.8052-week high ₹2856.30

-2.7% from the 52-week high · +183.8% above the low

Neogen Chemicals Ltd. engages in the manufacture of specialty chemicals which are used in pharmaceutical, engineering, and agro chemical industries. The company employs 493 full-time employees The company went IPO on 2019-05-08. The Company’s products include organic chemicals, advance intermediates, inorganic chemicals, chemistries and grignard reagents. The firm operates through three segments: organic chemicals, inorganic chemicals, and custom synthesis and manufacturing. Organic chemicals segment is involved in the manufacturing of organic bromine-based compounds, advanced intermediates, specialty compounds and Grignard reagents. The inorganic chemicals segment is involved in manufacturing inorganic lithium and bromine salts. Custom synthesis and manufacturing segment is involved in developing and manufacturing new processes and customized products.

The short version. NEOGEN reported revenue of ₹296 crore for Sep 2026, up 41.6% from a year earlier. Net profit was ₹8 crore (up 166.7% year on year). Return on equity was 3.5% in Mar 2026. Promoter holding was 48.31% in Sep 2026, down 2.91 points over 8 quarters.

1 · The price

How has the stock traded?

NEOGEN trades 2.7% below its 52-week high and 183.8% above its 52-week low.

Change over period: —

1M+12.0%
3M+19.4%
6M+64.0%
1Y+113.3%

2 · The business

Is it growing?

Sales, year on year+41.6%

Sep 2026 revenue of ₹296 cr.

Profit, year on year+166.7%

Sep 2026 net profit of ₹8 cr.

Net margin2.8%

1.2 pts higher than a year earlier.

3-year growth-16.8% profit

Revenue compounded at 7.9% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue296250247220209187203201
Net profit817114310210
Net margin %2.86.84.61.71.65.51.25.0
EPS (₹)2.746.254.321.41.283.890.913.79

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue862778691686487336306239
Net profit2935365045312921
Net margin %3.34.55.27.39.29.39.48.8
EPS (₹)10.913.213.5120.0417.913.4312.288.98

3 · The quality

How well does it turn capital into profit?

Return on equity was 3.5% in Mar 2026; debt to equity is 1.63.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %3.54.44.710.4
Return on capital %6.89.710.115.5
EBITDA margin %16.616.216.816.8
Net margin %3.34.55.17.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR7.9%20.9%
Profit CAGR-16.8%-1.7%
Debt to equity1.63
Interest cover1.6x
Current ratio1.17
P/E ratio188.3

4 · The owners

Who holds it, and are they adding?

Promoter holding48.31%

Down 2.91 pts over 8 quarters.

Foreign institutions4.51%

Down 3.22 pts over 8 quarters.

Domestic institutions23.43%

Up 0.9 pts over 8 quarters.

Mutual fund schemes36

+11 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter51.2251.2251.2251.2251.2251.2253.048.31-2.91
FII7.737.797.365.154.574.464.114.51-3.22
DII22.5322.7522.9625.2321.9922.6419.623.43+0.9
Public18.5118.2318.4518.3922.2121.6723.2823.74+5.23

Mutual fund holdings · Oct 2026

36 schemes hold this stock

25 the month before.

  • SAMCO SPECIAL OPPORTUNITIES FUND1.74% of NAV
  • Axis Innovation Fund1.73% of NAV
  • Mirae Asset Healthcare Fund1.41% of NAV
  • UNION INNOVATION & OPPORTUNITIES FUND1.15% of NAV
  • JM Flexi cap Fund1.03% of NAV
  • ICICI Prudential Commodities Fund0.98% of NAV
  • Bajaj Finserv Small Cap Fund0.9% of NAV
  • Invesco India Small cap Fund0.73% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for NEOGEN are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about NEOGEN

What is the NEOGEN share price?

NEOGEN (NEOGEN) last closed at ₹2,888.50, up 3.9% on the day. Its 52-week range is ₹979.80 to ₹2,856.30.

What is the market cap of NEOGEN?

NEOGEN has a market capitalisation of about ₹8,402 crore. Its price-to-earnings ratio is 188.3.

How are NEOGEN's latest results?

NEOGEN reported revenue of ₹296 crore for Sep 2026, up 41.6% from a year earlier. Net profit was ₹8 crore (up 166.7% year on year). Return on equity was 3.5% in Mar 2026. Promoter holding was 48.31% in Sep 2026, down 2.91 points over 8 quarters.

Who owns NEOGEN?

As of Sep 2026, shareholding was: Promoter 48.31%, FII 4.51%, DII 23.43%, Public 23.74%.

How many mutual funds hold NEOGEN?

36 mutual fund schemes held NEOGEN in October 2026. That compares with 25 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 19 Sep 2025 · Final Dividend - Rs. 1
  • 19 Sep 2024 · Final Dividend - Rs. 2
  • 25 Aug 2023 · Final Dividend - Rs. 3
  • 19 Sep 2022 · Final Dividend - Rs. 2.75
  • 16 Sep 2021 · Final Dividend - Rs. 2.25
  • 17 Sep 2020 · Final Dividend - Rs. 2

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.